ClinicalTrials.Veeva

Menu

Effects of the Soluble Mediators of Mastocytes on the Intestinal Epithelial Barrier and of the Enteric Nervous System During the Syndrome of the Irritable Bowel

C

Centre Hospitalier Universitaire de Nice

Status

Unknown

Conditions

Irritable Bowel Syndrome

Treatments

Procedure: Colic biopsies

Study type

Interventional

Funder types

Other

Identifiers

NCT00742118
05-API-08

Details and patient eligibility

About

Patients with irritable bowel syndrome (IBS) have increased intestinal permeability. In addition, mucosal soluble mediators are involved in the pathophysiology of pain in IBS. The investigators aimed to investigate:

  1. paracellular permeability in colonic biopsies of IBS patient
  2. the ability of soluble factors from colonic biopsies to reproduce in vitro these alterations

Enrollment

200 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients needing coloscopy

Exclusion criteria

  • Disrupted coagulation results
  • Cancer even healed
  • Known food allergy.
  • Alcohol consumption >30g/day

Trial design

Primary purpose

Basic Science

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

200 participants in 3 patient groups

2
Experimental group
Description:
patient with chronic inflammatory intestinal disease
Treatment:
Procedure: Colic biopsies
3
Other group
Description:
patient having no symptoms
Treatment:
Procedure: Colic biopsies
1
Experimental group
Description:
patient with irritable bowel syndrome
Treatment:
Procedure: Colic biopsies

Trial contacts and locations

1

Loading...

Central trial contact

Thierry PICHE, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems